A Microbial Signature Identifies Advanced Fibrosis in Patients with Chronic Liver Disease Mainly Due to NAFLD

The presence of advanced fibrosis is an important measure of the severity of chronic liver disease. Prior works that have examined the gut microbiome as a novel biomarker for advanced fibrosis have only examined patients with nonalcoholic fatty liver disease. Therefore, our goal was to examine the g...

Descripción completa

Detalles Bibliográficos
Autores principales: Dong, Tien S., Katzka, William, Lagishetty, Venu, Luu, Kayti, Hauer, Meg, Pisegna, Joseph, Jacobs, Jonathan P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7026172/
https://www.ncbi.nlm.nih.gov/pubmed/32066758
http://dx.doi.org/10.1038/s41598-020-59535-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7026172/
https://www.ncbi.nlm.nih.gov/pubmed/32066758
http://dx.doi.org/10.1038/s41598-020-59535-w

Ejemplares similares